Trial register facet
Trial records in growth hormone deficiency and growth-hormone secretagogue pharmacology — page 2
57 records bearing on growth hormone deficiency and growth-hormone secretagogue pharmacology.
Showing 0 records on this page
Records
57 documents · page 2 of 3
Table 1. Trial records on this page. The table sorts on any column and filters on the controls above; both operate on the records shown on this page only.
| Record | Compound | Phase | Status | Design | Randomised | Year | Certainty |
|---|---|---|---|---|---|---|---|
| GHRP2-JP-DIAGNOSTIC-QOLprogramme record | GHRP-2 | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 2006 | Very low |
| CJC-PH1-ASCENDING-OLEprogramme record | CJC-1295 | Phase 1 | Reported | Single-arm open-label | — | 2006 | Very low |
| GHRP2-JP-DIAGNOSTIC-PKprogramme record | GHRP-2 | Phase 1 | Reported | Phase 1 ascending dose | — | 2006 | Very low |
| IPA-PH1-GH | Ipamorelin | Phase 1 | Reported | Phase 1 ascending dose | — | 1998 | Low |
| IPA-PH1-GH-ELDERLYprogramme record | Ipamorelin | Phase 1 | Reported | Randomised, double-blind, placebo-controlled | — | 1998 | Very low |
| IPA-PH1-GH-OLEprogramme record | Ipamorelin | Phase 1 | Reported | Single-arm open-label | — | 1998 | Very low |
| IPA-PH1-GH-ADHERENCEprogramme record | Ipamorelin | Phase 1 | Reported | Observational | — | 1998 | Very low |
| IPA-PH1-GH-BIOMARKERprogramme record | Ipamorelin | Phase 1 | Reported | Randomised, double-blind, placebo-controlled | — | 1998 | Very low |
| IPA-PH1-GH-REGIONAL-CNprogramme record | Ipamorelin | Phase 3 | Reported | Randomised, double-blind, placebo-controlled | — | 1998 | Very low |
| HEX-PH1-GH | Hexarelin | Phase 1 | Reported | Phase 1 ascending dose | — | 1995 | Low |
| GHRP6-PH1-GH | GHRP-6 | Phase 1 | Reported | Phase 1 ascending dose | — | 1995 | Low |
| HEX-PH1-GH-DDIprogramme record | Hexarelin | Phase 1 | Reported | Randomised crossover | — | 1995 | Very low |
| GHRP6-PH1-GH-OLEprogramme record | GHRP-6 | Phase 1 | Reported | Single-arm open-label | — | 1995 | Very low |
| HEX-PH1-GH-HEPATIC-IMPprogramme record | Hexarelin | Phase 1 | Reported | Phase 1 ascending dose | — | 1995 | Very low |
| GHRP6-PH1-GH-ELDERLYprogramme record | GHRP-6 | Phase 1 | Reported | Randomised, double-blind, placebo-controlled | — | 1995 | Very low |
| HEX-PH1-GH-RENAL-IMPprogramme record | Hexarelin | Phase 1 | Reported | Phase 1 ascending dose | — | 1995 | Very low |
| GHRP6-PH1-GH-BIOMARKERprogramme record | GHRP-6 | Phase 1 | Reported | Randomised, double-blind, placebo-controlled | — | 1995 | Very low |
| HEX-PH1-GH-PKprogramme record | Hexarelin | Phase 1 | Reported | Phase 1 ascending dose | — | 1995 | Very low |
| GHRP6-PH1-GH-ADHERENCEprogramme record | GHRP-6 | Phase 1 | Reported | Observational | — | 1995 | Very low |
| HEX-PH1-GH-OLEprogramme record | Hexarelin | Phase 1 | Reported | Single-arm open-label | — | 1995 | Very low |
| GHRP6-PH1-GH-QOLprogramme record | GHRP-6 | Phase 1 | Reported | Randomised, double-blind, placebo-controlled | — | 1995 | Very low |
| GNRH-DIAGNOSTIC | Gonadorelin | — | Reported | Diagnostic accuracy | — | — | Moderate |
| GNRH-PULSATILE-HH | Gonadorelin | — | Reported | Single-arm open-label | — | — | Moderate |
| SERM-DIAGNOSTIC | Sermorelin | — | Reported | Diagnostic accuracy | — | — | Moderate |
page 2 of 3